229 related articles for article (PubMed ID: 24089560)
1. Alpha interferon restricts human T-lymphotropic virus type 1 and 2 de novo infection through PKR activation.
Cachat A; Chevalier SA; Alais S; Ko NL; Ratner L; Journo C; Dutartre H; Mahieux R
J Virol; 2013 Dec; 87(24):13386-96. PubMed ID: 24089560
[TBL] [Abstract][Full Text] [Related]
2. ADAR1 enhances HTLV-1 and HTLV-2 replication through inhibition of PKR activity.
Cachat A; Alais S; Chevalier SA; Journo C; Fusil F; Dutartre H; Boniface A; Ko NL; Gessain A; Cosset FL; Suspène R; Vartanian JP; Mahieux R
Retrovirology; 2014 Nov; 11():93. PubMed ID: 25389016
[TBL] [Abstract][Full Text] [Related]
3. Intracellular localization and cellular factors interaction of HTLV-1 and HTLV-2 Tax proteins: similarities and functional differences.
Bertazzoni U; Turci M; Avesani F; Di Gennaro G; Bidoia C; Romanelli MG
Viruses; 2011 May; 3(5):541-560. PubMed ID: 21994745
[TBL] [Abstract][Full Text] [Related]
4. Interferon-α (IFN-α) suppresses HTLV-1 gene expression and cell cycling, while IFN-α combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cells.
Kinpara S; Kijiyama M; Takamori A; Hasegawa A; Sasada A; Masuda T; Tanaka Y; Utsunomiya A; Kannagi M
Retrovirology; 2013 May; 10():52. PubMed ID: 23688327
[TBL] [Abstract][Full Text] [Related]
5. Distinct transformation tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and HTLV-2 is the result of postinfection T cell clonal expansion.
Kannian P; Yin H; Doueiri R; Lairmore MD; Fernandez S; Green PL
J Virol; 2012 Apr; 86(7):3757-66. PubMed ID: 22278223
[TBL] [Abstract][Full Text] [Related]
6. Insights on the pathogenicity of human T-lymphotropic/leukemia virus types I and II.
Cereseto A; Mulloy JC; Franchini G
J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S69-75. PubMed ID: 8797707
[TBL] [Abstract][Full Text] [Related]
7. Blocking HTLV-1/2 silent transmission in Brazil: Current public health policies and proposal for additional strategies.
Rosadas C; Menezes MLB; Galvão-Castro B; Assone T; Miranda AE; Aragón MG; Caterino-de-Araujo A; Taylor GP; Ishak R
PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009717. PubMed ID: 34555019
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of HTLV-I and II proviral load using real-time quantitative PCR with SYBR Green chemistry.
Lee TH; Chafets DM; Busch MP; Murphy EL
J Clin Virol; 2004 Dec; 31(4):275-82. PubMed ID: 15494269
[TBL] [Abstract][Full Text] [Related]
9. Differences in the ability of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 tax to inhibit p53 function.
Mahieux R; Pise-Masison CA; Lambert PF; Nicot C; De Marchis L; Gessain A; Green P; Hall W; Brady JN
J Virol; 2000 Aug; 74(15):6866-74. PubMed ID: 10888626
[TBL] [Abstract][Full Text] [Related]
10. Clonality of HTLV-2 in natural infection.
Melamed A; Witkover AD; Laydon DJ; Brown R; Ladell K; Miners K; Rowan AG; Gormley N; Price DA; Taylor GP; Murphy EL; Bangham CR
PLoS Pathog; 2014 Mar; 10(3):e1004006. PubMed ID: 24626195
[TBL] [Abstract][Full Text] [Related]
11. Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data.
Kwaan N; Lee TH; Chafets DM; Nass C; Newman B; Smith J; Garratty G; Murphy EL;
J Infect Dis; 2006 Dec; 194(11):1557-64. PubMed ID: 17083040
[TBL] [Abstract][Full Text] [Related]
12. [HTLV-I and HTLV-II virus].
Maniez-Montreuil M
Ann Biol Clin (Paris); 1998; 56(5):563-70. PubMed ID: 9769480
[TBL] [Abstract][Full Text] [Related]
13. NF-κB inhibition facilitates the establishment of cell lines that chronically produce human T-lymphotropic virus type 1 viral particles.
Zahoor MA; Philip S; Zhi H; Giam CZ
J Virol; 2014 Mar; 88(6):3496-504. PubMed ID: 24403591
[TBL] [Abstract][Full Text] [Related]
14. Comparative host protein interactions with HTLV-1 p30 and HTLV-2 p28: insights into difference in pathobiology of human retroviruses.
Doueiri R; Anupam R; Kvaratskhelia M; Green KB; Lairmore MD; Green PL
Retrovirology; 2012 Aug; 9():64. PubMed ID: 22876852
[TBL] [Abstract][Full Text] [Related]
15. Tax and overlapping rex sequences do not confer the distinct transformation tropisms of human T-cell leukemia virus types 1 and 2.
Ye J; Xie L; Green PL
J Virol; 2003 Jul; 77(14):7728-35. PubMed ID: 12829812
[TBL] [Abstract][Full Text] [Related]
16. Detection and characterization of human T-lymphotropic viruses.
Calabrò ML; Favero A; Chieco-Bianchi L
Antibiot Chemother (1971); 1994; 46():125-33. PubMed ID: 7826033
[No Abstract] [Full Text] [Related]
17. Human T-cell leukemia virus type 1 Tax modulates interferon-alpha signal transduction through competitive usage of the coactivator CBP/p300.
Zhang J; Yamada O; Kawagishi K; Araki H; Yamaoka S; Hattori T; Shimotohno K
Virology; 2008 Sep; 379(2):306-13. PubMed ID: 18678383
[TBL] [Abstract][Full Text] [Related]
18. miR-28-3p is a cellular restriction factor that inhibits human T cell leukemia virus, type 1 (HTLV-1) replication and virus infection.
Bai XT; Nicot C
J Biol Chem; 2015 Feb; 290(9):5381-90. PubMed ID: 25568327
[TBL] [Abstract][Full Text] [Related]
19. [HTLV-1, 2].
Fujii M; Niinuma A; Higuchi M
Nihon Rinsho; 2003 Mar; 61 Suppl 3():503-7. PubMed ID: 12718018
[No Abstract] [Full Text] [Related]
20. Inactivation of p53 by HTLV type 1 and HTLV type 2 Tax trans-activators.
Mahieux R; Pise-Masison CA; Nicot C; Green P; Hall WW; Brady JN
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1677-81. PubMed ID: 11080809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
